<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="19" ids="28790">Serotonin</z:chebi> and insulin are key regulators of homeostatic mechanisms in the hypothalamus </plain></SENT>
<SENT sid="1" pm="."><plain>However, in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, the hypothalamic responsiveness to <z:chebi fb="19" ids="28790">serotonin</z:chebi> is not clearly established </plain></SENT>
<SENT sid="2" pm="."><plain>We used a diabetic model, the Goto Kakizaki (GK) rats, to explore insulin receptor expression, insulin and <z:chebi fb="19" ids="28790">serotonin</z:chebi> efficiency in the hypothalamus and liver by means of Akt phosphorylation </plain></SENT>
<SENT sid="3" pm="."><plain>Insulin or dexfenfluramine (stimulator of <z:chebi fb="19" ids="28790">serotonin</z:chebi>) treatment induced Akt phosphorylation in Wistar rats but not in GK rats that exhibit down-regulated insulin receptor </plain></SENT>
<SENT sid="4" pm="."><plain>Studies in a <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo> cell line showed that <z:chebi fb="19" ids="28790">serotonin</z:chebi>-induced Akt phosphorylation is PI3-kinase dependent </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, in response to food intake, hypothalamic <z:chebi fb="19" ids="28790">serotonin</z:chebi> release was reduced in GK rats, indicating impaired responsiveness of this neurotransmitter </plain></SENT>
<SENT sid="6" pm="."><plain>In conclusion, hypothalamic <z:chebi fb="19" ids="28790">serotonin</z:chebi> as insulin efficiency is impaired in diabetic GK rats </plain></SENT>
<SENT sid="7" pm="."><plain>The insulin-<z:chebi fb="19" ids="28790">serotonin</z:chebi> cross-talk and impairment observed is one potential key modification in the brain during the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>